Evaluate Efficacy and Safety of ADVATE in the Standard Prophylaxis Treatment of Severe or Moderately Severe Hemophilia A
NCT02282410
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Hemophilia A
Interventions
DRUG:
ADVATE
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School